Biodesix, Inc. (BDSX)

Biodesix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	20.73	26.25	26.28	43.09	32.71	62.13
Cash & Short-Term Investments	20.73	26.25	26.28	43.09	32.71	62.13
Cash Growth	-50.90%	-0.15%	-39.00%	31.72%	-47.35%	1075.29%
Receivables	7.45	8.6	7.68	5.07	3.66	15.3
Inventory	1.6	1	1.4	1.4	2.9	3.2
Restricted Cash	0.1	0.1	0.1	0.1	0.1	0.2
Other Current Assets	2.57	3.54	4.22	3.68	4.25	5.31
Total Current Assets	32.45	39.48	39.68	53.33	43.61	86.14
Property, Plant & Equipment	30.34	29.6	29.61	8.82	4.18	3.18
Goodwill	15.03	15.03	15.03	15.03	15.03	15.03
Other Intangible Assets	4.87	5.87	7.91	9.8	11.62	13.26
Long-Term Deferred Charges	-	0.7	-	-	-	-
Other Long-Term Assets	5.05	6.56	6.86	5.92	1.66	3.46
Total Assets	87.74	97.24	99.1	92.91	76.1	121.07
Accounts Payable	2.97	2.19	2.93	1.69	1.66	8.96
Accrued Expenses	9.54	9.91	7.71	8.22	7.67	7.79
Current Portion of Long-Term Debt	0.02	0.02	0.05	0.05	0.02	11.84
Current Portion of Leases	2.01	1.51	0.25	1.54	-	-
Current Unearned Revenue	0.62	0.68	0.32	0.96	1.85	3.53
Other Current Liabilities	-	-	22.15	10.38	17.76	-
Total Current Liabilities	15.16	14.32	33.42	22.84	28.96	32.13
Long-Term Debt	46.78	36.41	35.23	25	9.99	15.93
Long-Term Leases	24.66	25.44	25.16	5.25	-	-
Long-Term Unearned Revenue	0	0.2	0.3	0.4	0.8	1.4
Other Long-Term Liabilities	-	-	0.41	18.8	16.62	30.45
Total Liabilities	86.6	76.37	94.52	72.3	56.37	79.9
Common Stock	0.15	0.15	0.1	0.08	0.03	0.03
Additional Paid-In Capital	486.06	483.23	424.05	387.95	321.67	299.95
Retained Earnings	-485.07	-462.5	-419.57	-367.42	-301.97	-258.81
Total Common Equity	1.14	20.88	4.58	20.61	19.73	41.17
Shareholders' Equity	1.14	20.88	4.58	20.61	19.73	41.17
Total Liabilities & Equity	87.74	97.24	99.1	92.91	76.1	121.07
Total Debt	73.47	63.38	60.69	31.85	10.01	27.77
Net Cash (Debt)	-52.74	-37.14	-34.41	11.24	22.7	34.36
Net Cash Growth	-	-	-	-50.49%	-33.93%	-
Net Cash Per Share	-0.36	-0.29	-0.42	0.27	0.83	7.10
Filing Date Shares Outstanding	146.63	145.98	96.94	77.97	31.31	26.58
Total Common Shares Outstanding	146.58	145.49	96.24	77.61	30.79	26.56
Working Capital	17.29	25.17	6.27	30.5	14.65	54.02
Book Value Per Share	0.01	0.14	0.05	0.27	0.64	1.55
Tangible Book Value	-18.76	-0.03	-18.36	-4.22	-6.92	12.88
Tangible Book Value Per Share	-0.13	-0.00	-0.19	-0.05	-0.22	0.48
Machinery	8.38	8.36	8.44	7.23	7.97	7.03
Construction In Progress	0.03	0.09	-	2.95	0.02	0.38
Leasehold Improvements	28.22	28.19	24.71	2.37	2.34	1.85

Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q